#1COTY INVESTOR PRESENTATION DB CONSUMER CONFERENCE JUNE 6, 2023 00.00#21 COTY A BEAUTY POWERHOUSE, WITH SIGNIFICANT WHITE SPACES LANCASTER SÉRUM PRINCIER LANCASTER CRÈME PRINCIÈRE#3Founded in 1904 in Paris, France COTY OUR LEGACY IN BEAUTY LAROSE JACQUEMINO OTY A global leader in beauty for over 100 years#4CONSUMER BEAUTY 41% TWO PROFITABLE DIVISIONS REACHING CONSUMERS ACROSS PRICE POINTS FY21 REVENUE BY DIVISION 59% CONSUMER BEAUTY PRESTIGE 38% 3Q23 FYTD REVENUE BY DIVISION 62% PRESTIGE#5DIVERSIFIED REGIONAL PORTFOLIO, WITH WHITE SPACE POTENTIAL 3Q FYTD COTY REVENUE MIX VS. BEAUTY INDUSTRY NORTH AMERICA (INCL. KYLIE) 30% [Beauty Industry: ~20%] WESTERN EUROPE 26% [Beauty Industry: ~20%] EASTERN EU & MEA 18% [Beauty Industry: ~8%1 CHINA 4% [Beauty Industry: ~13%] GLOBAL TRAVEL RETAIL 8% [Beauty Industry: ~10%] BRAZIL & LATAM 8% [Beauty Industry: ~9%] Market Data Source: GlobalData APAC 6% [Beauty Industry: ~20%]#6GLOBAL AND CATEGORY-LED R&D CENTERS OF EXCELLENCE COSMETICS CENTER OF EXCELLENCE (USA) SKINCARE CENTER OF EXCELLENCE (MONACO) FRAGRANCE CENTER OF EXCELLENCE (SWITZERLAND) SKIN & BODY CENTER OF EXCELLENCE (CHINA) BODYCARE CENTER OF EXCELLENCE (BRAZIL)#7LEADING EXPERTISE & IP IN BEAUTY FRAGRANCES 856 COLOR COSMETICS SKINCARE Years of expertise 180+ reinventing modern perfumery 160+ Years of expertise in Color Cosmetics 50+ Active skincare patents 85+ Published scientific studies Fragrance Scientists, 130+ Evaluators and 109+ Scientists, Evaluators and Industry experts Industry experts 120+ Dedicated skincare scientists New patent 80+ Active patents & 7 applications across patent applications Mascara (3), Lip (2), and Nail (2) Innovations in the 80+ pipeline#8BEAUTIFUL BRAND PORTFOLIO REACHING CONSUMERS ACROSS PRICE POINTS ULTRA-PREMIUM $150 - 450 INFINIMENT ORVEDA COTY PARIS Chloe ATELIER DES FLEURS PREMIUM + $50 - 150 PREMIUM $20-100 MASS $5 - 20 GUCCI BURBERRY LONDON ENGLAND LANCASTER SKKN BY KIM KYLIE philosophy BOSS MARC JACOBS tunne CALVIN KLEIN DAVIDOFF PARFUMS JIL SANDER adidas BOURJOIS PARIS - DAVID BECKHAM VERA WANG MAX FACTOR X COVERGIRL RIMMEL LONDON Sally Hansen#9OUR 6 STRATEGIC PILLARS #1 #2 #3 #4 #5 #6 Stabilize and grow consumer beauty makeup brands & mass fragrances Accelerate luxury fragrances & become a key player in prestige makeup Build skincare portfolio across both divisions Build e-commerce and direct-to- consumer expertise and capabilities Expand in China and Travel Retail, led by Prestige brands Become a beauty leader in sustainability#10DOUBLE-DIGIT CONSUMER BEAUTY SALES GROWTH Coty revenues and sell-out growing double-digits, driving market share gains for 5th consecutive quarter AIMM CLEAN FRESH AMMY RIMMEL LONDON KIND & FREE EYE DEFINER DELICIOUSLY CLEAN, GLASSY SHINE CLEA COVERGIRL YUM +10 BPS Cruelty Free INTERNATIONAL VEGAN FREE FREE RIMMEL +10 BPS NOVA FÓRMULA NOVA FORMULA SEM SILICONE SEM SILICONE NOVA FÓRMULA SEM SILICONE 72h 72h 72h nonange monange monange SENSÍVEL DETOV FRUTAS BRUNO BANANI +30 BPS MONANGE +20 BPS Source: NielsenIQ Market: B&M and E-com Period: Last 3 Months March 2023 Categories: Color Cosmetics Mass, Fragrances Mass, Deodorants, Shower Gels Countries: Argentina, Australia, Brazil, Canada, China, Czech Republic, France, Germany, Great Britain, Italy, Netherland, Poland, Spain, Switzerland, USA#11STRENGTHENING CORE & ENTERING WHITE SPACES THROUGH BALANCE OF OWNED & LICENSED BRANDS CORE LUXURY & ENTRY PRESTIGE FRAGRANCES CORE CONSUMER BEAUTY WHITE SPACE PRESTIGE SKINCARE WHITE SPACE MAKEUP ULTRA PREMIUM NICHE FRAGRANCES Chloé BURBERRY HUGO BOSS | CALVIN KLEIN COVERGIRL RIMMEL LONDON LANCASTER ATELIER DES FLEURS SIGNATURES ORVEDA GUCCI BURBERRY GUCCI LONDON ENGLAND Sally Hansen MAX FACTOR ✗ philosophy JIL SANDER SKKN BY KIM THE ALCHEMIST'S GARDEN MARC JACOBS DAVIDOFF PARFUMS BOURJOIS PARIS- INFINIMENT COTY PARIS ~$40B Market / Est. MSD-HSD % Growth ~$40B Market / Est. LSD-MSD % Growth ~$70B Market / Est. MSD-HSD % Growth ~$4B Market / Est. 20% Growth Source: GlobalData, NPD, Nielsen, Coty estimates Coty Owned / Anchored Brand Coty Licensed Brand#12COTY SINCE 1904 A NEW BEGINNING Most AMBITIOUS and PREMIUM fragrance project to date INFINIMENT COTY PARIS Collection of 14 scents LAUNCHING IN 2024 PATENT-PENDING for the formulation and packaging#13ORVEDA OMNIPOTENT CONCENTRATE One of the most POTENT SERUMS of all time - CONCENTRATION of active ingredients up to 15x TIMES MORE than the average skincare RVEDA Worldwide DTC launch in AUGUST 2023 PATENT-PENDING D-TECH EMULSION ORVED THE FRENCH GREEN BIOTEC LA SÈVE PRIMORDIALE THE VITAL SAP ORVE LA GRLEE BIOTIC#14000000000€ 60030000000 4000000000 ORVEDA ERM ORVEDA Upgraded Orveda Counters in NYC & Paris: Recent sales have DOUBLED vs. prior monthly run-rate#15LANCASTER LIGNE PRINCIERE LAUNCH 4月7日20点 兰嘉丝汀直播专场 携手明星讲师文森特、时尚美妆达人弦子 登上御时畅想航班,一起云游摩纳哥! ▶银泰百货 LANCASTER Intime Department Store 兰嘉丝汀 MONACO 御颜奢享之旅 N-Frey 时尚美妆博主 弦子Freyc 文森特Vincent 明星讲师 4月7日 20:00-22:00 A 兰嘉丝汀御颜霜 LANCASTER MONACO 但龄新肌焕容年轻 LANCASTER 爆款新品 音app扫码观看 Recent KOL livestreaming session on Douyin generated over >$300K in sales in ~3.5 hours Conversion at new counters inline to ahead of beauty peers, with Ligne Princiere driving majority of sales#16CREATING #BEAUTYTHATLASTS AND PROGRESSING ON OUR ESG JOURNEY 2141 with science- based targets SCIENCE BASED TARGETS DRIVING AMBITIOUS CORPORATE CLIMATE ACTION New carbon targets approved by science backed target initiative Chloé NEW POLICY GENDER NEUTRAL PARENTAL LEAVE COTY'S GENDER PAY EQUITY COMMITMENT: Pay equitably for similar roles and performance, regardless of gender, by 2022 Pioneer in fragrances using carbon-captured ethanol & First carbon positive fragrance in the world#172 STRONG FINANCIAL PROGRESS#18Q3: STRONG AND BROAD-BASED REVENUE GROWTH +15% LFL SALES GROWTH IN Q3 BENEFITTED FROM RETAILER RESTOCKING POST HOLIDAYS VOLUME GROWTH IN BOTH SEGMENTS CONSUMER BEAUTY +12% LFL 38% Q3 REVENUES PRESTIGE +16% LFL APAC AMERICAS +4% LFL +15% LFL 12% 62% 46% EMEA +18% LFL Q3 REVENUES 42%#19Q4 QTD: MAINTAINING STRONG GROWTH MOMENTUM AMERICAS Continued strong growth, led by momentum in Prestige Fragrances, Travel Retail, and LATAM EMEA Continued strong growth, led by momentum in Prestige Fragrances and Travel Retail APAC Accelerating growth, led by China re-opening and Travel Retail#20STRONG VALUE ACCRETION ~12-13% LFL CAGR (ex FX) ~12-13% CAGR (INC. >$40M FX HURT) ~$5.30B ~$5.45- 5.48B ~$955- 965M ~$905M ~$4.63B ~$762M x8 $0.28 $0.05 $0.38- 0.39 FY21 FY22 FY23E FY21 FY22 FY23E FY21 FY22 FY23E NET REVENUES Adjusted EPS excludes mark-to-market on equity swap ADJUSTED EBITDA ADJUSTED EPS#21STRONG MARGIN EXPANSION ~60.0% UP ~ 400bps ~64% ~63.7% ~22% UP ~500-600bps UP ~ 400bps HIGH ~13% ~28% 20% ~11.6% RANGE ~9.4% FY21 FY22 FY23E FY21 FY22 FY23E FY21 FY22 FY23E ADJUSTED GROSS MARGIN ADVERTISING & CONSUMER PROMOTION ADJ. OPERATING MARGIN#22STRONG DELEVERAGING AND CASH GENERATION DOWN >3X ~6.8x ~4.7x ~$145M ~$550M >$400M Towards 3x FY21 FY22 CY23E FY21 FY22 FY23E FY22 FCF included one-time working capital benefits LEVERAGE FREE CASH FLOW#233 ATTRACTIVE GROWTH ALGORITHM#24ACCELERATING SALES AND PROFIT MOMENTUM FY22 FY23E FY23-26E NET REVENUES $5.30B +9-10% LFL CAGR Upper end of +6-8% LFL CAGR GROSS MARGIN 63.7% Modest Expansion Mid 60s % by '25 $955-965M FY26 & Beyond +6-8% LFL CAGR Expanding EBITDA $905M 1 TAX RATE ~28% EPS 2 $0.28 $0.38-0.39 Mid 20s % CAGR 3 DILUTED SHARES 834M 860-870M Gradual Reduction Mid-to-High 20% +9-11% CAGR Mid-to-High 20% +9-11% CAGR Mid-to-High 20% Mid to High Teens % CAGR ~800M 1 Assuming no significant changes in tax regulations 2 Excludes mark-to-market on equity swap 3 Reflects fully diluted share count, including convertible preferred shares; reported share count may differ due GAAP anti-dilutive provisions, with no material impact to estimated adjusted EPS in FY23 and beyond#25ACCELERATE FREE CASH FLOW GENERATION FY22 FY23E FY26E ADJ EBITDA $905M $955-965M - $1.2Bn $1.3Bn 1X CASH COSTS <$150M <$50M CASH INTEREST ~$215M CASH TAXES ~$100M WORKING CAP Positive CAPEX ~$175M Low $200s FREE CASH FLOW ~$550M LEVERAGE RATIO 4.7x Mid $200s ~$100M Positive >$400M Towards 3x CY23 NM Low $100s Low $100M Positive Low to mid $200s >$500M ~2x by CY25#26STRENGTHENING CAPITAL STRUCTURE TO ENABLE DELEVERAGING AND CAPITAL RETURNS CY22 CY23-CY25 (Cumulative) CAPITAL ALLOCATION BY END OF CY25 PRIORITIES Net Debt <$3.9B Financial Leverage ~4.1x Free Cash Flow ~$450M FCF >$1.2B (>$0.4B / year) + Wella Divestiture >$1B ~75% Deleverage ~25% Capital Returns NO Substantive M&A Net Debt <$2.5B Financial Leverage ~2x Capital Returns & Reinvestment ~$0.5B (incl. $0.4B buyback announcement)#27COTY SINCE 1904#28DISCLAIMER Forward-Looking Statements Certain statements in this presentation are forward-looking statements. These forward-looking statements reflect the Company's current views with respect to, among other things, strategic planning, targets and outlook for future reporting periods (including the extent, timing and concentration of revenue, expense and profit trends, changes in operating cash flows and cash flows from operating activities and investing activities, expected drivers of sales and profitability in future periods, expected future tax rates, the impact of currency exchange rate volatility, the impact of inflationary pressures, and the expected timing and impact of pricing and other measures to offset inflationary pressures), the wind down of the Company's operations in Russia (including timing and expected impact), the Company's future operations and strategy including the expected implementation and related impact of its strategic priorities), allocation and amount of advertising and consumer promotion costs, expected shelf space trends, plans with respect to research and development and innovation pipeline, allocation and amount of research and development investments, investments, licenses and portfolio changes, product launches and relaunches or rebranding (including their expected timing and impact), ongoing and future cost efficiency, optimization and restructuring initiatives and programs, strategic transactions (including their expected timing and impact), and synergies, savings, performance, cost, timing and integration of acquisitions and investments, plans with respect to opportunities to leverage assets including through public offerings, expectations and/or plans with respect to joint ventures (including Wella, any potential future divestiture, and the timing and size of any related distribution or return of capital), the Company's capital allocation strategy and payment of dividends (including suspension of dividend payments and the duration thereof, and any plans to resume cash dividends on common stock or continue to pay dividends in cash on preferred stock), future share repurchases, future cash flows, liquidity and borrowing capacity (including any debt refinancing or deleveraging activities), timing and size of cash outflows and debt deleveraging, the timing and extent of any future impairments, synergies, savings, impact, cost, timing and implementation of the Company's ongoing transformation agenda (including operational structure changes, operational execution and simplification initiatives, cost reductions and supply chain changes), expected impact, cost, timing and implementation of e-commerce and digital initiatives, expected impact, cost, timing and implementation of sustainability initiatives (including progress, plans and goals), the expected impact of geopolitical risks including the ongoing war in Ukraine on our business operations, sales outlook and strategy, the expected impact of global supply chain challenges and/or inflationary pressures (including as a result of COVID-19 and/or the war in Ukraine) and expectations regarding future service levels, expectations regarding the impact of the easing of COVID-19 restrictions in Asia, the priorities of senior management, and the Company's ability to support its planned business operations in the near-term and long-term basis. These forward-looking statements are generally identified by words or phrases, such as "anticipate", "are going to", "estimate", "plan", "project", "expect", "believe", "intend", "foresee", "forecast", "will", "may", "should", "outlook", "continue", "temporary", "target", "aim", "potential", "goal" and similar words or phrases. These statements are based on certain assumptions and estimates that we consider reasonable, but are subject to a number of risks and uncertainties, many of which are beyond the control of the Company, which could cause actual results to differ materially from such statements. Such risks and uncertainties are identified in the periodic reports Coty has filed and may file with the Securities and Exchange Commission (the "SEC") including, but not limited to: the Company's ability successfully implement its multi-year transformation agenda and to develop and achieve its global business strategies and strategic priorities, compete effectively in the beauty industry and achieve the benefits contemplated by its strategic initiatives within the expected time frame or at all; the timing, costs and impacts of future divestitures (and the amount and use of proceeds from any such transactions); the impact of COVID-19 (or future similar events); the integration of acquisitions with the Company's business, operations, systems, financial data and culture and the ability to realize synergies, avoid future supply chain and other business disruptions, reduce costs and realize other potential efficiencies and benefits (including through its restructuring initiatives) at the levels and at the costs and within the time frames contemplated or at all; disruptions in the availability and distribution of raw materials and components needed to manufacture the Company's products; managerial, operational, regulatory, legal and financial risks, including diversion of management attention to and management of cash flows, expenses and costs associated with multiple ongoing and future strategic initiatives, internal reorganizations and restructuring activities, including its transformation agenda; any unanticipated problems, liabilities or integration or other challenges associated with a past or future acquired business, joint ventures or strategic partnerships which could result in increased risk or new, unanticipated or unknown liabilities, including with respect to environmental, competition and other regulatory, compliance or legal matters and litigation or investigations by governmental authorities; currency exchange rate volatility and currency devaluation and/or inflation; changes in the demand for the Company's products due to declining or depressed global or regional economic conditions, and declines in consumer confidence or spending; global political and/or economic uncertainties, disruptions or major regulatory or policy changes, and/or the enforcement thereof that affect the Company's business, financial performance, operations or products, including the impact of the war in Ukraine and any related escalation or expansion thereof; the Company's ability to retain and attract key personnel; the Company's ability to adapt its business to address climate change concerns and to respond to increasing governmental and regulatory measures relating to ESG matters; and the impact of senior management transitions and organizational structure changes. The foregoing review of important factors should not be construed as exhaustive and should be read in conjunction with the other cautionary statements that are included elsewhere. More information about potential risks and uncertainties that could affect Coty's business and financial results is included under "Risk Factors" and "Management's Discussion and Analysis of Financial Condition and Results of Operations" in Coty's Annual Report on Form 10-K for the fiscal year ended June 30, 2022 and other periodic reports Coty has filed and may file with the SEC from time to time. Any forward-looking statements made in this presentation are qualified in their entirety by these cautionary statements. All forward-looking statements are made only as of the date of this presentation, and, Coty undertakes no obligation, other than as may be required by applicable law, update or revise any forward-looking or cautionary statements to reflect changes in assumptions, the occurrence of events, unanticipated or otherwise, or changes in future operating results over time or otherwise. Non-GAAP Financial Measures In this presentation, Coty presents certain non-GAAP financial measures that we believe enable management and investors to analyze and compare the underlying business results from period to period, including constant currency, organic like- for-like (LFL) and adjusted metrics, adjusted operating income, adjusted gross margin, as well as adjusted earnings before interest, taxes, depreciation and amortization ("adjusted EBITDA"), adjusted EPS, net debt or financial net debt, economic net debt, free cash flow and immediate liquidity. Constant currency information compares results between periods as if exchange rates had remained constant period-over-period, with the current period's results calculated at the prior-year period's rates. The term "like-for-like" describes the Coty's core operating performance, excluding the financial impact of (i) acquired brands or businesses in the current year period until Coty has twelve months of comparable financial results, (ii) divested brands or businesses or early terminated brands, generally, in the prior year non-comparable periods, to maintain comparable financial results with the current fiscal year period and (iii) foreign currency exchange translations to the extent applicable. Adjusted metrics exclude nonrecurring items, purchase price accounting-related amortization, acquisition-related costs, restructuring costs, stock-based compensation, costs related to market exit, loss on early extinguishment of debt, asset impairment charges, and certain other information as noted within this presentation. Free cash flow is defined as net cash provided by operating activities, less capital expenditures, and net debt is defined as total debt less cash and cash equivalents. "Immediate liquidity" is defined as the sum of available cash and cash equivalents and available borrowings under Coty's Revolving Credit Facility. These non-GAAP financial measures should not be considered in isolation, or as a substitute for, or superior to, financial measures calculated in accordance with GAAP. To the extent that Coty provides guidance, it does so only on a non-GAAP basis and does not provide reconciliations of such forward-looking non-GAAP measures to GAAP due to the inherent difficulty in forecasting and quantifying certain amounts that are necessary for such reconciliation, including adjustments that could be made for restructuring, integration and acquisition-related expenses, amortization expenses, adjustments to inventory, and other charges reflected in our reconciliation of historic numbers, the amount of which, based on historical experience, could be significant. Reconciliation of these non-GAAP financial measures to the nearest comparable GAAP financial measures are contained in the press release attached as Exhibit 99.1 to the Form 8-K filed with the SEC May 9, 2023. Outlook Information In this presentation, Coty presents outlook information as of June 6, 2023.